Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03821467

Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography in Healthy Subjects

Short- and Long-term Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography Measurements in Healthy Subjects - a Pilot Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Dual beam Doppler Fourier-domain Optical coherence tomography (DOCT) is a noninvasive technique to quantify total retinal blood flow. To enable further development of this technique it is essential to assess short- and long-term reproducibility of DOCT blood flow measurements.

Detailed description

In the present study, total retinal blood flow will be measured with DOCT at multiple time points to gain information of short- and long-term reproducibility. In addition, provocation with flickering light will be performed, which is known to lead to vasodilatation and an increase in retinal blood flow in healthy subjects. Vessel diameters will also be measured using the Dynamic Vessel Analyzer (DVA).

Conditions

Interventions

TypeNameDescription
DEVICEDual beam Doppler Fourier-domain OCT (DOCT)Retinal blood flow will be assessed using DOCT.
DEVICEDynamic Vessel Analyzer (DVA)Retinal vessel diameters and oxygen saturation will be measured with the DVA device.
DEVICEOptical coherence tomography (OCT)Retinal morphology will be imaged using OCT.

Timeline

Start date
2018-11-19
Primary completion
2025-12-12
Completion
2025-12-12
First posted
2019-01-29
Last updated
2025-05-16

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03821467. Inclusion in this directory is not an endorsement.